Crystal Structure of CYP106A2 in Substrate-Free and Substrate-Bound Form

被引:18
|
作者
Janocha, Simon [1 ]
Carius, Yvonne [2 ]
Hutter, Michael [3 ]
Lancaster, C. Roy D. [2 ]
Bernhardt, Rita [1 ]
机构
[1] Univ Saarland, Dept Biochem, Campus B2-2, D-66123 Saarbrucken, Germany
[2] Univ Saarland, Dept Biol Struct, ZHMB, Bldg 60, D-66421 Homburg, Germany
[3] Univ Saarland, Ctr Bioinformat, Campus E2-1, D-66123 Saarbrucken, Germany
关键词
abietic acid; CYP106A2; heme distortion; oxidoreductases; X-ray diffraction; 11-KETO-BETA-BOSWELLIC ACID KBA; BACILLUS-MEGATERIUM; ESCHERICHIA-COLI; CYTOCHROMES P450; MOLECULAR EVOLUTION; HYDROXYLATION; SYSTEM; CRYSTALLIZATION; BIOSYNTHESIS; PROGESTERONE;
D O I
10.1002/cbic.201500524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CYP106A2 from Bacillus megaterium ATCC 13368 is known as a bacterial steroid hydroxylase that is also capable of hydroxylating a variety of terpenoids. To analyze the substrate specificity of this enzyme further, different resin acids of the abietane and pimarane types were tested with regard to binding and conversion. Product formation could be shown for all tested substrates. Spectroscopic studies revealed type I binding spectra for isopimaric acid, but dehydroabietic acid did not induce a high-spin shift of the enzyme. Interestingly, binding of abietic acid resulted in a type II difference spectrum typical for nitrogenous inhibitors. Co-crystallization of CYP106A2 with abietic acid and structure determination revealed bending of the heme cofactor when abietic acid was bound in the active site. Quantum chemical calculations strongly suggest that this heme distortion is the cause of the unusual spectroscopic characteristics.
引用
收藏
页码:852 / 860
页数:9
相关论文
共 50 条
  • [31] Crystal structure of 4-chlorobenzoate:CoA ligase/synthetase in the unliganded and aryl substrate-bound states
    Gulick, AM
    Lu, XF
    Dunaway-Mariano, D
    BIOCHEMISTRY, 2004, 43 (27) : 8670 - 8679
  • [32] Defining the structure of the substrate-free state of the DnaK molecular chaperone
    Swain, JF
    Sivendran, R
    Gierasch, LM
    FROM PROTEIN FOLDING TO NEW ENZYMES, 2001, 68 : 69 - 82
  • [33] CRYSTAL-STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS-PUTIDA CYTOCHROME-P-450
    POULOS, TL
    FINZEL, BC
    HOWARD, AJ
    BIOCHEMISTRY, 1986, 25 (18) : 5314 - 5322
  • [34] Characterization of the structure, dynamics and allosteric pathways of human NPP1 in its free form and substrate-bound complex from molecular modeling
    Barbeau, Xavier
    Mathieu, Patrick
    Paquin, Jean-Francois
    Lague, Patrick
    MOLECULAR BIOSYSTEMS, 2017, 13 (06) : 1058 - 1069
  • [35] Substrate-bound structure of the E. coli multidrug resistance transporter MdfA
    Heng, Jie
    Zhao, Yan
    Liu, Ming
    Liu, Yue
    Fan, Junping
    Wang, Xianping
    Zhao, Yongfang
    Zhang, Xuejun C.
    CELL RESEARCH, 2015, 25 (09) : 1060 - 1073
  • [36] Substrate binding to 15β-hydroxylase (CYP106A2) probed by FT infrared spectroscopic studies of the iron ligand CO stretch vibration
    Simgen, B
    Contzen, J
    Schwarzer, R
    Bernhardt, R
    Jung, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (03) : 737 - 742
  • [37] Substrate-bound structure of the E. coli multidrug resistance transporter MdfA
    Jie Heng
    Yan Zhao
    Ming Liu
    Yue Liu
    Junping Fan
    Xianping Wang
    Yongfang Zhao
    Xuejun C Zhang
    Cell Research, 2015, 25 : 1060 - 1073
  • [38] STRUCTURE OF SUBSTRATE-FREE DIOL DEHYDRATASE REVEALS ACTIVATION MECHANISM OF ADENOSYLCOBALAMIN
    Shibata, N.
    Masuda, J.
    Toraya, T.
    Morimoto, Y.
    Yasuoka, N.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C93 - C93
  • [39] PHYSICAL-PROPERTIES OF THIN SUBSTRATE-FREE LIQUID-CRYSTAL FILMS
    STOEBE, T
    HUANG, CC
    INTERNATIONAL JOURNAL OF MODERN PHYSICS B, 1995, 9 (18-19): : 2285 - 2319
  • [40] Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure:: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4
    Lewis, DFV
    Lake, BG
    Dickins, M
    Eddershaw, PJ
    Tarbit, MH
    Goldfarb, PS
    XENOBIOTICA, 1999, 29 (04) : 361 - 393